Elypta
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$30.41M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elypta is a biotechnology company that develops a metabolism-based liquid biopsy platform for the early detection and monitoring of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elypta Comparables
Compare Elypta with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dxcover | 79% | |
| Biomark Diagnostics Inc. | 77% | |
| CanSense | 73% | |
Elypta Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Series A | Jun 20, 2022 | ||||
| Seed | Dec 1, 2019 | ||||
| Grant | Feb 4, 2019 |
Key People
Founding team and executive leadership
Elypta Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nina Capital | Seed, Series A |
| Bonnier Capital | Series A |
| Hillclimber | Series A |
| Navigare Ventures | Series A |
| Norrsken Foundation | Seed |
| Industrifonden | Series A, Seed |
| Sciety | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors grew 96% MoM.
- Apr 7, 2025
Dr. Hilja Ibert appointed to the Board of Directors.
Elypta Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elypta's valuation, stock price, and market status.